|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT01012570 |
|
Date of registration:
|
11/11/2009 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
August 2009 |
|
Target sample size:
|
34 |
|
Recruitment status: |
Terminated |
|
URL:
|
http://clinicaltrials.gov/show/NCT01012570 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Prospective
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Switzerland
| | | | | | | |
|
Contacts
|
|
Name:
|
01 Studienregister MasterAdmins |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
UniversitaetsSpital Zuerich |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
- CDAI > 220 und < 450
- Biologika naiv
- CD seit > 6 Monaten
Exclusion criteria:
- other TNF-Blocker
- Steroids > 40 mg
- Malignoma in der Anamnesis
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Crohn's Disease
|
|
Intervention(s)
|
|
Drug: Application of Adalimumab
|
|
Secondary ID(s)
|
|
HUM-07-019
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|